Welcome to our dedicated page for Gyrodyne SEC filings (Ticker: GYRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From Flowerfield鈥檚 63-acre entitlement push to the Cortlandt Manor medical park leases, Gyrodyne鈥檚 story is documented in its SEC filings. Investors searching 鈥淕yrodyne insider trading Form 4 transactions鈥� or 鈥淕yrodyne quarterly earnings report 10-Q filing鈥� usually want clarity on how each zoning decision, lease renewal, or rights offering impacts land value and potential liquidating distributions. Unfortunately, those answers sit in dense 8-Ks about planning board meetings or 200-page 10-Ks packed with fair-value tables鈥攅nough complexity to make even seasoned professionals ask for 鈥淕yrodyne SEC filings explained simply.鈥�
Stock Titan supplies that simplicity. Our AI parses every submission the moment it hits EDGAR鈥攚hether it鈥檚 a subscription-rights prospectus or 鈥淕yrodyne Form 4 insider transactions real-time鈥濃�攁nd turns it into short, plain-English briefs. With comprehensive coverage of all filing types, you gain instant context: 鈥淕yrodyne earnings report filing analysis鈥� links NOI changes to entitlement spending, while alerts surface lease expirations buried inside exhibits. The result? 鈥淯nderstanding Gyrodyne SEC documents with AI鈥� becomes a workflow, not a wish.
Dig deeper when you need to. The 鈥淕yrodyne annual report 10-K simplified鈥� tracks parcel-level valuation swings; 10-Qs reveal entitlement costs quarter by quarter; the proxy shows 鈥淕yrodyne proxy statement executive compensation鈥� after the Star Equity accord; Forms 4 capture 鈥淕yrodyne executive stock transactions Form 4.鈥� And when a zoning approval drops, our engine tags the 鈥淕yrodyne 8-K material events explained,鈥� delivering real-time insights you can act on. Stop scanning PDFs鈥攗se Stock Titan to monitor cash-flow trends, compare segment yields, and make informed decisions faster.
Gyrodyne (GYRO) 8-K: Subsidiary GSD Flowerfield LLC signed a definitive agreement (30-Jul-25) to sell an ~49-acre vacant parcel at the Flowerfield complex in St. James, NY to B2K Smithtown LLC for $24.0-$28.74 million, with the final price tied to the number of market-rate units ultimately approved.
Key deal terms: (i) $250k earnest deposit; (ii) 90-day due-diligence period permitting full refund; (iii) closing deadline on the earlier of 8 months after town site-plan approval or 60 days after waiver, with a latest estimated closing of Dec-2027 (Aug-2028 if options exercised); (iv) purchase is contingent upon subdivision and other approvals within 18 months, after which the buyer may terminate or waive.
Management extended the estimated company liquidation date to 31-Dec-2027 and projects Net Asset Value in liquidation at $32.6 million, or $14.83 per share, as of 30-Jun-25, inclusive of expected transaction proceeds and additional carrying costs.
Full agreement (Ex 10.1) and related press release (Ex 99.1) filed.
FAQ
What is the current stock price of Gyrodyne (GYRO)?
What is the market cap of Gyrodyne (GYRO)?
What does Gyrodyne, LLC do?
Where are Gyrodyne's properties located?
What recent agreement has Gyrodyne entered into?
What is Gyrodyne's planned rights offering?
How will Gyrodyne use the proceeds from the rights offering?
What changes will the new stock incentive plan bring?
How does Gyrodyne plan to enhance property value?
What is the significance of the Flowerfield property?
What financial strategies is Gyrodyne currently employing?
Where can I find more information about Gyrodyne, LLC?
